Evaluation of IL-35 and hs-CRP in Iraqi Patients with Cardiovascular diseases

Abstract

    Interleukin-35 (IL-35) is a novel anti-inflammatory of IL-12 family member cytokine. High sensitive C- reactive protein (hs-CRP) is a marker of inflammation disease. This study was obtained to estimate the concentrations of IL-35 and hs-CRP in cardiovascular diseases Iraqi patients. The study contained 79 subjects divided into two groups, 47 (21 male and 26 female) suffering from cardiovascular diseases and 32 as control group. The concentration of IL-35 and hs-CRP was measured by enzyme- linked immune sorbent assay (ELISA). The results revealed that the concentrations of IL-35 and hs-CRP are increased in patients group. IL-35 is strongly expressed in human advanced plaque and hs-CRP. Therefore these two biomarkers could be useful as addition in diagnosis of cardiovascular diseases.         A significant increase of IL-35 and hs-CRP levels in patients group compared with controls (P<0.005) and there was a positive correlation between IL-35 with hs-CRP in patients group. The results of this study revealed that IL-35 is a potentially anti-inflammatory marker in cardiovascular diseases.